chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 10 minutes of vaccine admission, arm had severe pain and stiffness. Stiffness and pain increased over the next hour to the point of limiting all movement and usage of entire arm from fingers to shoulder. Within 24 hours of vaccination, joints throughout body ached mildly and experienced mild stiffness. These symptoms have fluctuated in severity since date of vaccination, but have not subsided 100%. Small joints of hands & feet are stiff and painful 24/7. Other joints are stiff/painful daily but not constantly. No swelling or redness noticed at the joints.
This spontaneous report as received from a other health professional refers to unspecified number of patient of unknown age and gender. Licensed nurse reported that since 17-JUL-2014, improperly stored (Merck) VARIVAX (dose, strength, route and lot number were not reported) was dispensed to patients. No adverse effects were noted. Follow up information has been received from Licensed Practical Nurse. Nurse did not have the information (patient identifiers, lot number, expiration date or dates of vaccine administration) available. Follow up information has been received from Licensed Practical Nurse referring to a 12 month old patient of unknown gender. On 24-SEP-2014 the patient was vaccinated with improperly stored (Merck) VARIVAX lot # J013905, expiration date 30-OCT-2015. This is one of several reports received from the same reporter. Additional information is not expected because all follow ups requested to complete the case were received.
Patient notes 4 hours after injection developed pain in the left knee, with acute swelling and gout symptoms , similar to his previous history of gout flares
Thursday Morning had covid vaccine, felt tired, Friday night diarrhea, vomiting and stopped during the day, stayed in bed all day saturday, was able to eat saturday again, continues to have loose stools, is taking pepto bismol. There is not any data regarding this as a reaction however will file a VAERS report per pt request. Is pushing fluids and does not have any further concerns. Will call provider if symptoms continue.
Tinnitus. Fuzzy, ringing in ears. Tinny hearing. Inner ear inflammation.
Large local reaction swelled to the size of palm at injection site.  Hot to the touch and patient had difficulty moving arm.  Applied ice to site with little relief.
I seem to have developed "COVID arm," where I have a rash around the injection site. It doesn't hurt but it is very warm to the touch and swollen. The rash is about the size as a baseball.
This spontaneous report was received from the patient's father, concerning a male patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not provided. On 18-JUN-2018, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) lot # reported as 001543 with expiration date on 15-JUL-2019, for prophylaxis; and also with DTAP-IPV lot # C5325BA with expiration date on 14-NOV-2019 (strength, dose, route of administration or anatomical location were not provided for neither of them). Late that night, he was running a high fever at approximately 101 (units not provided). The outcome of high fever and the causality assessment for the suspect vaccines were not provided.
On 12/26/2022, in the morning, I started having abdominal pain.  It continued on and off with nausea throughout the week. On 12/31/2022, I was on a ship and the nausea was bad.  I went to the hospital.  I began vomiting and diarrhea. I was released at 11:00 that night, after 4-6 hours. Diarrhea continued for 5 days. The entire cruise, I had to go back for IV fluids twice a day.  They released me to my room.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (the arm a little warm but it didn't hurt that bad after the first dose) and FEELING HOT (the arm a little warm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A, 023C21A and 084J21A) for COVID-19 vaccination. Concurrent medical conditions included Heart disorder (diagnosed about 20 years ago.) and Diabetes (diagnosed about 20 years ago.).Concomitant products included METFORMIN for Diabetes, VITAMIN D3 for an unknown indication.On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On 20-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (the arm a little warm but it didn't hurt that bad after the first dose) and FEELING HOT (the arm a little warm). At the time of the report, PAIN IN EXTREMITY (the arm a little warm but it didn't hurt that bad after the first dose) and FEELING HOT (the arm a little warm) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.The patient's additional concomitant medication included a lot of vitamins (D3 and others) and unspecified medication for heart. No treatment drugs were reported.This case was linked to MOD-2022-457665 (Patient Link).
Constipation and change in feeding patter started after vaccines were given. Initially started infant probiotics which helped the infant stool independently once before unable to have a bowel movement again. Then treated with glycerin suppositories every other day x 5 days. Last report infant was able to stool on her own again.
Arm very warm; Redness; Soreness; A spontaneous report was received from a consumer concerning a female patient of unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, redness, soreness and arm very warm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 18 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: unknown) for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events redness, soreness and arm very warm. No treatment information was provided.  Action taken with mRNA-1273 in response to the events, redness, soreness, arm very warm was not reported.   On an unknown date the outcome of events include, redness, soreness and arm very warm was unknown.; Reporter's Comments: This case concerns a female of unknown age who experienced nonserious expected vaccination site warmth, erythema, and pain.  Event onset occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Chest pain, shortness of breath, doctors in emergency, emergencies, my own doctor never figured out what I had until I had some x-rays done, they saw heart inflammation and I made an appointment with doctor but until Sep 9, 2021 my pain was very intense that I could no longer work and I had to go see a Cardiologist with electros and echo they saw fluid in the mlm pericardium and I was in emergency 8/20/2021.
Lymphadenopathy - Right side glands in neck swollen, sore throat on right side only, Axillary swelling & pain. Pain across right shoulder down to right shoulder  blade.
Patient reported on July 24th had red bumps all around waist - on July 26th reported to doctor lesions/pustules spreading and getting bigger - diagnosed with shingles, given antiviral.
Information has been received from a nurse referring to an unspecified number of unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored GARDASIL 9 (lot # L007560, expiration date 15-JUN-2017, strength, dose, lot#, expiration date and route were unknown). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I have had hypothyroidism for the past 18 years and have been taking a stable/consistent dose of levothyroxine to manage it. As of March 2021 (prior to any covid vacccination) my TSH thyroid levels were normal. I received my 1st dose of the Pfizer vaccine at the end of March 2021, the 2nd dose of Pfizer in April 2021, and the 3rd booster of Moderna in November 2021. I noticed that I had increased symptoms of thyroid dysfunction toward the end of 2021. After getting a blood test in March 2022, my TSH thyroid levels were abnormally low - and my levothyroxine dosage had to be adjusted after nearly 15 years. Ever since March 2022, my TSH levels have remained low, despite changing dosages every 6 weeks, and I am still trying to get my thyroid levels back to normal. I believe the covid vaccine has impacted my thyroid functionality, since my thyroid levels have always been maintained steadily until after I took the vaccination. My hypothyroidism has now switched to hyperthyroidism and I am showing symptoms of Grave's Disease.  While I have no regrets or qualms about taking the vaccine (and would do it again as/when needed). I did want to report these effects for general awareness for others who may be thyroid patients. As a female of childbearing age, having a dysfunctional thyroid and less-than-optimal hormone levels puts me at a risk for infertility, miscarriages, and other pregnancy/birth complications. I am hoping to continue treating my thyroid so it goes back to being stable, but want to bring this to the medical community's attention. Thanks.
Felt unwell; Body aches; Chills; Fever of 103.5 Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt unwell), PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever of 103.5 Fahrenheit) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Continuous positive airway pressure. Concurrent medical conditions included Pulmonary arterial hypertension, Peripheral swelling, Restless legs syndrome, Headache, Dyspnoea exertional and Oedema peripheral. Concomitant products included PARACETAMOL (TYLENOL) for Headache, TREPROSTINIL DIOLAMIN (ORENITRAM) for Pulmonary arterial hypertension, BOSENTAN (TRACLEER [BOSENTAN]), WARFARIN SODIUM and SILDENAFIL CITRATE (REVATIO) for an unknown indication.    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced MALAISE (Felt unwell), PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever of 103.5 Fahrenheit). In April 2021, MALAISE (Felt unwell) had resolved. At the time of the report, PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever of 103.5 Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 103.5 fahrenheit (High) 103.5 Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Treprostinil  1.5 mg tid
Upper right arm 2-3 x normal size, red, warm. Mother giving Tylenol and applying ice. Dr. contacted by mother following PC to PHN.
Extreme chills and body aches. I could feel every joint, every muscle and even my bones aches. I was unable to move. When the heating pad slid off my arm I couldn?t move enough to put it back in place.  This was extremely bad for 24 hours. I was unable to eat. The next 24 hours I remained in bed  except for about 3 hours to eat. A little supper. I did go to work on Monday, but I was still aching and very rundown. I did not start to feel better until Thursday. I am still more run down than usual.
A physician via Merck Pharmaceuticals reported the occurrence of an allergic reaction in a 46 y.o. female who was vaccinated with Hep B recombinant (Engerix-B) for prophylaxis. The subject had previously experienced an allergic reaction manifested by persistent eye redness to a contact lens solution containing thimerosal. She subsequently had to use a thimerosal-free solution. Concurrent medications were not specified. On 4/23/91 at 9:00, the vaccinee received her first injection of Engerix-B (lot ENG630A4; expiry, 2/23/92). W/in 6 hrs post-immunization she experienced body aches, and back ache. She subsequently experienced cutaneous sensitivity and migratory paresthesias which persisted for several weeks. The physician made a diagnosis of "allergic reaction to the thimerosal." The reporting physician stated that the events were possibly related to Engerix-B administration. The Engerix-B immunization series was discontinued. The events revolved in May 1991.
Fever (101 degrees F), still ongoing into day three, chills, muscle ache, headache, swelling of lymph nodes in my right underarm
after getting 3 vaccines the patient had symptoms on 01Jan2022 and tested positive for Rapid Ag COVID 1/2 awaiting PCR results presumend positive; after getting 3 vaccines the patient had symptoms on 01Jan2022 and tested positive for Rapid Ag COVID 1/2 awaiting PCR results presumend positive; Booster; This is a spontaneous report received from a non-contactable reporter (Other HCP) from product quality group.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 12Oct2021 (Lot number: FF2589) at the age of 27 years as dose 3 (booster), single, administration date 16Feb2021 (Lot number: EL3247) as dose 2, single and administration date 26Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant) with onset 12Oct2021, outcome "unknown", described as "Booster"; VACCINATION FAILURE (medically significant) with onset 02Jan2022, outcome "unknown", COVID-19 (medically significant) with onset 02Jan2022, outcome "recovering" and all described as "after getting 3 vaccines the patient had symptoms on 01Jan2022 and tested positive for Rapid Ag COVID 1/2 awaiting PCR results presumend positive". The event "after getting 3 vaccines the patient had symptoms on 01jan2022 and tested positive for rapid ag covid 1/2 awaiting pcr results presumend positive" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (02Jan2022) positive; (02Jan2022) awaiting results presumend positive. It was unknown if therapeutic measures were taken as a result of covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: A contributory role of BNT162B2 to event after getting 3 vaccines the patient had symptoms on 01Jan2022 and tested positive for Rapid Ag COVID 1/2 awaiting PCR results presumend positive cannot be excluded based on temporal association and available information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
This report described the occurrence of migraine headaches in a male patient who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The patient received injections of Lymerix on 3/24/00 (lot LY128A2), 4/20/00 (lot LY136B9), and 9/27/00 (lot LY128A2). The vaccine was administered on a 0, 1, and 6 month schedule rather than the recommended schedule of 0, 1, and 12 months. On 9/3/03, the patient's attorney alleged that the patient suffered neck pain after his third vaccination along with migraine headaches. The onset of his symptoms is not clear at this time. Treatment and outcomes of the alleged events were not reported.
My left arm at injection site of my moderna vaccine became 4 inch diameter red hard hot to the touch and very sore. My joints ached for 30 hours after injection.  30 minutes after injection my face felt cold and tingly like I had been given novicane in my face. That went away after two hours.
Significant edema & erythema at injection site at 48 hours; significant axillary lymphadenopathy (vs adenitis) 48 hours after injection.
Severe dizziness, nauseous, stomach burning sensation, numbness in left arm where shot was given still sore after 5 days and still having dizziness.
1120 admin. TDAP IM (L) delt - pt then went to Lab for a Hgb. Patient returned to exam room at 1145 and sat in chair. At 1147 patient became pale, mildly diaphoretic with bradycardia at 43 BPM given orange juice and crackers when able to sit - sent to ER by private auto with father for cardiac enzymes. No ? noted.
1036 C/O Heart racing. BP 218/111, HR 118, resp 18, sats 97%. Reports Hx of HTN took BP meds this am. AAOX4 DENIES DIZZINESS. Client daughter present. 1045 BP 198/104, HR 96, resp 16, sat 97%. 12 lead EKG done reg rhythm. 1100 BP 176/95, HR 85, sats 97%, Resp 16 11:15 BP 171/90, HR 80, sats 98%. C/O feeling tired requesting to go to the ER states her blood pressure has never been that high before. 11:19 Left with her daughter. Client daughter states she will take her to the ER. First vaccine.
Donor called today 01/07/15 at 13:30 PM He stated about 23:55 PM 01/05/15 after his tetanus injection on 01/05/15 his arm (L deltoid) started hurting and he became short of breath for a brief period of time, but it subsided. He went today to the doctor 01/07/15 and told he had possible cellulitis and was offered antibiotics and pain medication, which he declined. Requested donor to come to facility. He stated he could not had to be at work at 14:30. He ask if I could write an excuse for work then said he was going to another doctor today, he proceeded to say he might come in later today.
2 shots in each shoulder at different times when pain got very bad/ on 27Mar had slight dull pain in left shoulder where I got the shot; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 71-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified date single followed by patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported) second 2 via an unspecified route of administration on 22Mar2021 single for Covid-19 immunization. Medical history included shoulder pain from an unknown date and unknown if ongoing (I have had pain in both shoulders for many years). The patient concomitant medications were not reported. On 27March Patient had slight dull pain in left shoulder where patient got the shot, pain gone next day. On 15Jul had severe pain in same spot, next day pain was gone but not just in that area, all the pain was gone in both shoulders. The outcome of the event was recovered on 28Jul2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from an unknown age female patient concerning on herself. The patient's concurrent conditions and medical history were not reported. On an unknown date, approximately in 2008, reporter as "7 seven years ago", the patient was vaccinated with the first dose of GARDASIL, injection, (route of administration, anatomical location, lot number and expiration date were not provided). She did not completed the series for unspecified reasons. On an unknown date, approximately in July 2015m reporter as "two months ago", the patient was vaccinated with the second dose of GARDASIL, injection, (route of administration, anatomical location, lot number and expiration date were not provided). The reporter stated that she would follow up with her physician for her third and final dose of the series. There were not adverse events reported. There was not a product quality issue involved. Additional information is not expected since the reporter details are not available.
Pea-sized water blister showed up at the injection site/blister the size of a dime near the injection site; redness around it; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (Pea-sized water blister showed up at the injection site/blister the size of a dime near the injection site), ERYTHEMA (redness around it) and VACCINATION SITE PAIN (sore at the injection site) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE VESICLES (Pea-sized water blister showed up at the injection site/blister the size of a dime near the injection site), ERYTHEMA (redness around it) and VACCINATION SITE PAIN (sore at the injection site). In March 2021, VACCINATION SITE VESICLES (Pea-sized water blister showed up at the injection site/blister the size of a dime near the injection site) had resolved. At the time of the report, ERYTHEMA (redness around it) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Event (PT: Vaccination site vesicles) outcome was updated to resolved with duration and end date details.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report was received from a office manager via field representative, refers to a 83 year old female patient. Patient's pertinent medical history, drug reactions/allergies and concomitant medications were unknown by the reporter. In approximately 2014 (also reported as about 2 years ago), the patient was vaccinated with ZOSTAVAX, 1 dose, subcutaneously (SQ), (lot#/expiry date unknown). The patient received ZOSTAVAX at the age of 81. Patient then developed shingles at 82 (in 2015, about a year ago) and was on pain medications afterwards. Patient was given treatment for the events. The outcome of the events was recovered. Causality assessment was not provided. Patient was seen by the physician. No product quality complain (PQC) was involved. No further adverse event information provided. Additional information has been requested.